StAbilize™

against antibody aggregation

Management and Board

Associate Professor Daniel Christ
Founder and Chief Scientific Officer

Daniel is the Founder and Chief Scientific Officer of Solvanix. He presently heads the Antibody Therapeutics Laboratory at the Garvan Institute of Medical Research in Sydney and holds a conjoint appointment as Associate Professor of Medicine at UNSW Australia.

read more
Dr Philip Wallace
Head of Product and Business Development

Dr Wallace joined Solvanix at its incorporation as the Head of Product- and Business- Development. He works closely with the inventor of the StAbilze™ technology, CSO and Founder Dr Daniel Christ on the Company’s product development and business development.

read more
Dr Jenny Harry
Non-Executive Director

Dr Harry is a non-executive director of Solvanix Pty Ltd. She is also Chair of QUT Enterprise Holdings Pty Ltd and holds non-executive directorships on the QUT bluebox and QUT Creative Industries boards.

read more
Dr Chris Smith
Non-Executive Director

Chris is an Investment Manager at Brandon Capital Partners. Brandon Capital Partners makes seed and venture capital investments for the development and international growth of Australian life science companies.

read more